Here, using various transplantable tumor models, we evaluated how the TME imprints Blimp1+ Treg cells and how disruptions of their suppressive activity reshape local and systemic immune responses as well as responses to PD-1 checkpoint blockade. This evidence concerns the gene PRDM1 and neoplasm.